Dynamic changes in bioelectrical impedance vector analysis and phase angle in acute decompensated heart failure.

Area of Science:

• Cardiology
• Biomedical Engineering
• Clinical Nutrition

Background:

• Acute decompensated heart failure (ADHF) is frequently associated with fluid retention and altered hydration status.
• Monitoring hydration status is crucial for managing ADHF patients and assessing treatment efficacy.
• Bioelectrical impedance vector analysis (BIVA) and phase angle are non-invasive methods to assess body composition and hydration.

Purpose of the Study:

• To determine if bioelectrical impedance vector analysis (BIVA) and phase angle can detect changes in hydration status during ADHF hospitalization and after clinical stabilization.
• To correlate BIVA-derived hydration status with clinical parameters and patient outcomes in ADHF.

Main Methods:

• Fifty-seven patients admitted for ADHF were assessed at admission, discharge, and 3 months post-discharge.
• Evaluated parameters included dyspnea, weight, brain natriuretic peptide, and bioelectrical impedance parameters (resistance, reactance, phase angle).
• Statistical analysis using generalized estimating equations and chi-square tested variations across the three time points.

Main Results:

• During hospitalization, patients showed clinical improvement with significant increases in resistance/height, reactance/height, and phase angle, indicating improved hydration.
• BIVA detected significant congestion in 61% of patients at admission, who experienced greater weight loss and dyspnea improvement.
• Hydration status, assessed by BIVA, shifted from congestion at admission to potential dehydration at discharge, normalizing by chronic stability.

Conclusions:

• BIVA and phase angle effectively monitor hydration status changes in ADHF patients, mirroring clinical recovery.
• BIVA's ability to classify congestion at admission identifies patients with more significant clinical changes during treatment.
• These findings support BIVA as a valuable tool for managing fluid balance in ADHF.